A preliminary trial of the effect of recombinant human growth hormone on short-term linear growth and glucose homeostasis in children with Crohn's disease

Clinical Endocrinology

Volumn 74, Issue 5, 2011, Pages 599-607

  Wong, S C ^a   Kumar, P ^b   Galloway, P J ^c   Blair, J C ^b   Didi, M ^b   Dalzell, A M ^b   Hassan, K ^c   Mcgrogan, P ^c   Ahmed, S Faisal ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b ALDER HEY CHILDREN S HOSPITAL   (United Kingdom)

^c ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HUMAN GROWTH HORMONE;

ADOLESCENT; ARTICLE; BODY HEIGHT; CHILD; CHILD GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GROWTH RETARDATION; HUMAN; MALE; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD;

EID: 79953757632     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2011.03977.x     Document Type: Article

References (38)

1. Wong, S.C., MacRae, V.E., McGrogan, P., et al. (2006) The role of pro-inflammatory cytokines in inflammatory bowel disease growth retardation. Journal of Pediatric Gastroenterology and Nutrition, 43, 144-155. (Pubitemid 44180496)
2. Wong, S.C., Smyth, A., McNeill, E., et al. (2010) The growth hormone-insulin like growth factor 1 axis in children & adolescents with inflammatory bowel disease & growth retardation. Clinical Endocrinology (Oxford), 73, 220-228.
3. Bannerjee, K., Camacho-Hübner, C., Babinska, K., et al. (2004) Anti-inflammatory and growth-stimulating effects precede nutritional restitution during enteral feeding in Crohn disease. Journal of Pediatric Gastroenterology and Nutrition, 38, 270-275.
4. Pfefferkorn, M., Burke, G., Griffiths, A., et al. (2009) Growth abnormalities persist in newly diagnosed children with crohn disease despite current treatment paradigms. Journal of Pediatric Gastroenterology and Nutrition, 48, 168-174.
5. Malik, S., Wong, S.C., Bishop, J., et al. (2011) Improvement in growth of children with Crohn's Disease following anti-TNFα therapy can be independent of pubertal progress and glucocorticoid reduction. Journal of Pediatric Gastroenterology and Nutrition, 52, 31-37.
6. Mushtaq, T., Bijman, P., Ahmed, S.F., et al. (2004) Insulin like growth factor-I augments chondrocyte hypertrophy and reverses glucocorticoid mediated growth retardation in fetal mice metatarsal cultures. Endocrinology, 145, 2478-2486. (Pubitemid 38535075)
7. MacRae, V.E., Farquharson, C., &, Ahmed, S.F., (2006) The restricted potential for recovery of growth plate chondrogenesis and longitudinal bone growth following exposure to pro-inflammatory cytokines. Journal of Endocrinology, 189, 319-328.
8. MÃ¥rtensson, K., Chrysis, D., &, Sävendahl, L., (2004) Interleukin-1beta and TNF-alpha act in synergy to inhibit longitudinal growth in fetal rat metatarsal bones. Journal of Bone and Mineral Research, 19, 1805-1812. (Pubitemid 41103431)
9. Davies, U.M., Jones, J., Reeve, J., et al. (1997) Juvenile rheumatoid arthritis. Effects of disease activity and recombinant human growth hormone on insulin-like growth factor 1, insulin-like growth factor binding proteins 1 and 3, and osteocalcin. Arthritis and Rheumatism, 40, 332-340. (Pubitemid 27114097)
10. Simon, D., Prieur, A.M., Quartier, P., et al. (2007) Early recombinant human growth hormone treatment in glucocorticoid-treated children with juvenile idiopathic arthritis: a 3-year randomized study. Journal of Clinical Endocrinology and Metabolism, 92, 2567-2573. (Pubitemid 47037359)
11. Hardin, D.S., Ellis, K.J., Dyson, M., et al. (2001) Growth hormone improves clinical status in prepubertal children with cystic fibrosis: results of a randomized controlled trial. Journal of Pediatrics, 139, 636-642. (Pubitemid 33097426)
12. Mauras, N., George, D., Evans, J., et al. (2002) Growth hormone has anabolic effects in glucocorticosteroid-dependent children with inflammatory bowel disease: a pilot study. Metabolism, 51, 127-135. (Pubitemid 34092448)
13. Wong, S.C., Hassan, K., McGrogan, P., et al. (2007) The effects of recombinant human growth hormone on linear growth in children with Crohn's Disease and short stature. Journal of Pediatric Endocrinology and Metabolism, 20, 1315-1324.
14. Slonim, A.E., Bulone, L., Damore, M.B., et al. (2000) A preliminary study of growth hormone therapy for Crohn's Disease. New England Journal of Medicine, 342, 1633-1637. (Pubitemid 30341532)
15. Cole, T.J., Freeman, J.V., &, Preece, M.A., (1995) Body mass index reference curves for the UK, 1990. Archives of Disease in Childhood, 73, 25-29.
16. Freeman, J.V., Cole, T.J., &, Chinn, S., et al. (1995) Cross sectional stature and weight reference curves for the UK, 1990. Archives of Disease in Childhood, 73: 17-24.
17. Tanner, J.M., &, Whitehouse, R.H., (1978) Growth and Development Record: Sitting Height and Sub-ischial Leg Length. Intergrated Series No 61 and 62. Castlemead Publications, Hertfordshire.
18. Hyams, J.S., Ferry, G.D., Mandel, F.S., et al. (1991) Development and validation of a paediatric Crohn's Disease activity index. Journal of Pediatric Gastroenterology and Nutrition, 12, 439-447.
19. Shepanski, M.A., Markowitz, J.E., Mamula, P., et al. (2004) Is an abbreviated pediatric crohn's disease activity index better than the original? Journal of Pediatric Gastroenterology and Nutrition, 39, 68-72.
20. Craig, M.E., Hattersley, A., &, Donaghue, K.C., (2009) Definition, epidemiology and classification of diabetes in children and adolescents. Pediatric Diabetes, 10 (Suppl. 12), 3-12.
21. Brabant, G., von zur Muhlen, A., Wuster, C., et al. (2003) Serum insulin like growth factor 1 reference values for an automated chemiluminescence immunoassay system: results from a multicentre study. Hormone Research, 60: 53-60. (Pubitemid 36928670)
22. Wong, S.C., MacRae, V.E., Gracie, J.A., et al. (2008) Inflammatory cytokines in juvenile idiopathic arthritis: effects on physical growth and the insulin-like-growth factor axis. Growth Hormone IGF Research Society, 18, 369-378. (Pubitemid 351944032)
23. Heyman, M.B., Garnett, E.A., Wojcicki, J., et al. (2008) Growth hormone treatment for growth failure in pediatric patients with Crohn's Disease. Journal of Pediatrics, 153, 651-658.
24. Beattie, R.M., Camacho-Hübner, C., Wacharasindhu, S., et al. (1998) Responsiveness of IGF-I and IGFBP-3 to therapeutic intervention in children and adolescents with Crohn's Disease. Clinical Endocrinology (Oxford), 49, 483-489. (Pubitemid 28475341)
25. Han, X., Sosnowska, D., Bonkowski, E.L., et al. (2005) Growth hormone inhibits signal transducer and activator of transcription 3 activation and reduces disease activity in murine colitis. Gastroenterology, 129, 185-203. (Pubitemid 41002054)
26. Williams, K.L., Fuller, C.R., Dieleman, L.A., et al. (2001) Enhanced survival and mucosal repair after dextran sodium sulfate-induced colitis in transgenic mice that overexpress growth hormone. Gastroenterology, 120, 925-937. (Pubitemid 32193189)
27. Kara, E., Sungurtekin, H., Sungurtekin, U., et al. (2004) The effect of recombinant human growth hormone (rhGH) on trinitrobenzene sulfonic acid induced colitis in rats: an experimental study. Inflammatory Bowel Diseases, 10, 112-115. (Pubitemid 38332170)
28. Denson, L.A., Kim, M.O., Bezold, R., et al. (2010) A randomized controlled trial of growth hormone in active pediatric Crohn's Disease. Journal of Pediatric Gastroenterology and Nutrition, 51, 130-139.
29. Graham, M.F., Diegelmann, R.F., Elson, C.O., et al. (1988) Collagen content and types in the intestinal strictures of crohns disease. Gastroenterology, 94, 257-65. (Pubitemid 18054760)
30. Fruchtman, S., Simmons, J.G., Fuller, C.R., et al. (2004) Suppresor of cytokine signaling (SOCS) limit fibrogenic actions of growth hormone and insulin like growth factor 1 in intestinal myofibroblasts. Gastroenterology, 126, A-138.
31. Theiss, A.L., Fuller, R., Simmons, J.G., et al. (2005) Growth hormone reduces the severity of fibrosis associated with chronic intestinal inflammation. Gastroenterology, 129, 204-219. (Pubitemid 41002055)
32. Zeeh, J.M., Mohapatra, N., Lund, P.K., et al. (1998) Differential expression and localization of IGF1 and IGF binding proteins in inflammed rat colon. Journal of Receptor and Signal Transduction Research, 18, 265-280. (Pubitemid 29017937)
33. Goldberg, R.B., (2009) Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications. Journal of Clinical Endocrinology and Metabolism, 94, 3171-3182.
34. Bismuth, E., Chevenne, D., Czernichow, P., et al. (2010) Moderate deterioration in glucose tolerance during high dose growth hormone therapy in glucocorticoid treated patients with juvenile idiopathic arthritis. Hormone Research in Pediatrics, 73, 465-472.
35. Hannon, T.S., Danadian, K., Suprasongsin, C., et al. (2007) Growth hormone treatment in adolescent males with idiopathic short stature: changes in body composition, protein, fat and glucose metabolism. Journal of Clinical Endocrinology and Metabolism, 92, 3033-3039. (Pubitemid 47236367)
36. Bareillie, P., Azcona, C., Matthews, D.R., et al. (1999) Lipid profile, glucose tolerance and insulin sensitivity after more than four years of growth hormone therapy in non growth hormone deficient adolescents. Clinical Endocrinology, 51, 347-353. (Pubitemid 29439055)
37. Sas, T., Mulder, P., Aanstoot, H.J., et al. (2001) Carbohydrate metabolism during long term growth hormone treatment in children with short stature born small for gestational age. Clinical Endocrinology, 54, 243-251. (Pubitemid 32193527)
38. Radetti, G., Pasquino, B., Gottardi, E., et al. (2004) Insulin sensitivity in Turner's syndrome: influence of GH treatment. European Journal of Endocrinology, 151, 351-354. (Pubitemid 39307322)